Depression Found to Be Independently Associated with Recurrent Chest Pain
On multivariable regression models, depression was a significant independent predictor of 30-day chest pain recurrence after adjustment.
Angina
Beta-Blocker Use Post-Heart Attack Called Into Question
They found that patients who only took the ACE inhibitor, or an angiotensin receptor blocker, and statin were no more likely to die than those who took all 3 prescribed treatments.
FDA: Coffee Products Laced with Active Pharmaceutical Ingredients
Although these coffee products are labeled as a “natural” or “herbal” they can cause serious harm.
Non-Invasive ECG Device Gets FDA Clearance
Clinical data from the Turbulence study (n=1,807) showed CADence had comparable performance to a SPECT nuclear stress test in excluding obstructive CAD in patients with chest pain and risk factors.
Nitroglycerin Products Recalled Due to Low Potency
The products were distributed to healthcare facilities nationwide between March 9 and June 1 and have expiration dates ranging from June 6 to August 15, 2017.
NSAIDs May Up MI Risk Within the First Week of Use
Drug dose, duration of use, and recency of use were all evaluated.
FDA Fast Tracks Gene Therapy for Chronic Angina Patients
XC001 is an investigational cardiovascular angiogenic gene therapy that promotes angiogenesis to provide arterial blood flow to myocardial regions with inadequate blood supply.
How Metoprolol Helps Reduce Damage During Heart Attack
The data showed patients treated with metoprolol during acute myocardial infarction had a 40% reduced extent of microvascular obstruction.
High-Dose Vitamin D: Does It Prevent Cardiovascular Disease?
But effects of daily or weekly dosing require further study
Angina Prevention Medication Discontinued
The decision to stop manufacturing the product is business related.
